Farag Kameel D. bought AKTX
June 24, 2026 · Form 4 insider transaction
Farag Kameel D. bought 7,353 shares of Akari Therapeutics, Plc at $3.74 per share, a transaction worth $27.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
7,353
Price
$3.74
Total value
$27.5K
InsiderFarag Kameel D.
Role—
SecurityAmerican Depositary Shares representing Ordinary Shares
Transaction codeA: Grant or award
Transaction dateJune 24, 2026
Filing dateJune 25, 2026
Shares owned after19,452
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These American Depositary Shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 80,000 ordinary shares with a par value of $0.000000005 per ordinary share. The RSUs vested in full on June 24, 2026.